Home/ Supplements/ Niacin/ FitMiss Burn

FitMiss Burn

product on market Capsule MusclePharm Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 43% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains B vitamins, magnesium, and chromium, which support energy metabolism and glucose regulation with moderate to strong evidence. Olive leaf extract is included for its antioxidant properties, though evidence for weight loss is more limited. The ingredient profile maintains a high safety rating.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for FitMiss Burn
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
45
Servings
Other Combinations
Product Type
43%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

2 mg (10% DV)
Within RDA (0.1× RDA) 196 studies (A:5, B:63)
2 mg (20% DV)
Within RDA (0.4× RDA) 2 studies — no high-quality reviews
3 mg (1% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
666 mcg (4% DV)
Market median: 500.0mg (115 products)
66 mcg (55% DV)
1.9× RDA — within safe limits 199 studies (A:1, B:55)
Potassium
1.16 mg
Revolutionary Women's 6 Stage Weight Loss Blend
1494 mg

Other Ingredients

Gelatin Magnesium Stearate Silicon Dioxide Maltodextrin
Claims

Label Claims — Verification

Unverified Structure/Function
Info

Product Information

Formulation Notes

Clinically tested ingredients

Women's 6 stage fat burning system Rapid weight loss-increases thermogenesis Appetite suppressant & mood balancer Boosts metabolism & increases energy

Metadata

Product Details

DSLD Entry Date2021-02-25
Product TypeOther Combinations
FormCapsule
DSLD ID244564
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.